PICC and subclavian vein catheterization in patients with malignant tumor of the application of comparative study.doc

 PAGE \* MERGEFORMAT 4 PICC and subclavian vein catheterization in patients with malignant tumor of the application of comparative study Author: Gao Xiao-Ling Yang Shurong Ping Yongrong Multiple intravenous chemotherapy is one of the main method to treat malignant tumors, chemotherapy and toxic side effects of drugs, such as the inadvertent leakage of blood vessels, may lead to local light red, swelling, heat, pain, severe cases can cause skin and tissue damage, so that patients phlebitis and leakage to withstand the pain of injury, and even under the influence of a course of treatment. Therefore, the choice of blood vessels in patients with malignant tumors is very important. January 2007 ~ December 2008, I Division in the course of intravenous chemotherapy in patients with malignant tumors were taken peripherally inserted central venous (PICC) and subclavian vein catheterization, this clinical study these two kinds of approach the success rate, operation time, retention time, pain rate, incidence of complications were compared. conclusion, intravenous chemotherapy in patients with malignant tumor, the choice of PICC catheter is superior to the subclavian vein catheterization, is worthy to be popularized the results reported as follows: A clinical data and methods 1.1 The clinical data of our department in June 2006 ~ December 2008, admitted to be a long-term infusion in patients with malignant tumor patients, 55 cases were selected infusion channels are divided into two groups, the elbow a good line of vascular conditions, PICC tube into 25 patients, aged 35 ~ 78 years, catheterization time was 28 to 220 days, with an average catheterization time was 68 days, in this case the PICC group. Acceptance of subclavian vein catheterization 30 cases, aged 18 to 75 years, with an average 41 years old, catheter time, 22 ~ 80 days, with an average catheterization time was 36 days, in this case for the lock to wear group. The first two groups of patients were receivi